Harbor Capital Advisors, Inc. Axogen, Inc. Transaction History

Harbor Capital Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	SELL	$3.61 - $7.76 $31,172 - $67,007	-8,635 Reduced 35.62%	15,604 $106,000
Q3 2023 Oct 20, 2023	BUY	$4.68 - $9.26 $45,269 - $89,571	9,673 Added 66.41%	24,239 $121,000
Q2 2023 Jul 11, 2023	BUY	$8.5 - $10.38 $123,811 - $151,195	14,566 New	14,566 $132,000

163

36.1M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $765M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.